Sen. Rand Paul

Maddy summaryThis bill creates a legal process allowing generic drug manufacturers to challenge inaccurate patent listings by brand-name drug companies. Specifically, it permits generic applicants to file lawsuits seeking court orders to correct or delete misleading "use codes" in patent records related to a drug's method of use. This directly affects generic drug makers and brand-name sponsors who list patents for drug applications under FDA approval pathways. The key mechanism requires courts to address listings that don't match actual patents, cover unrelated uses, or are overly broad, aiming to clear patent-related barriers for generic competition.

Maddy summaryThe ADAPT 2.0 Act (S 1132) allows U.S. drug manufacturers to seek approval for new drugs using clinical and safety data from countries where the drug is already approved, such as the United Kingdom and South Africa. It requires the FDA to review these applications within 90 days and automatically approve them if the drug meets specific criteria, including being approved in the foreign country, safe, effective, and meeting manufacturing and patent requirements. The bill mandates the FDA to establish a new Foreign Drug Review Advisory Committee to evaluate applications within 60 days and publish approval decisions online. It also requires sponsors to conduct post-approval studies for certain drugs and submit promotional materials for review before dissemination. This law directly affects drug manufacturers seeking faster U.S. market access and the FDA’s review process for foreign-approved therapies.

Maddy summaryThis bill repeals two specific legal authorizations for U.S. military force against Iraq: the 1991 authorization (Public Law 102-1) and the 2002 authorization (Public Law 107-243). If enacted, it would end the legal basis for military operations in Iraq under these two resolutions. The repeal directly affects the executive branch’s authority to use military force against Iraq under these specific laws. It does not create new policy but removes existing legal permissions.

Maddy summaryThis bill (SJRES 22) seeks to block a specific rule issued by the Department of Education regarding federal student loan modifications. It targets the rule titled "Waivers and Modifications of Federal Student Loans," which included a one-time debt relief program announced in October 2022. The resolution requests Congress disapprove the rule under the Congressional Review Act, preventing the Department from implementing it. If approved, the rule would have no legal effect, directly affecting how student loan borrowers could access modifications or debt relief under that specific policy.

Maddy summaryThis bill prohibits public colleges and universities from denying religious student groups access to campus facilities or official recognition that is available to other student organizations. It directly affects public institutions of higher education and religious student organizations by requiring equal treatment based on the institution's policies for non-religious groups. The key provision states that no federal funds can be withheld from an institution that denies a religious group access to facilities or recognition due to its religious beliefs, practices, speech, leadership standards, or conduct codes. The law applies to all public colleges receiving funds under the Higher Education Act of 1965.

Maddy summaryThe NIH Reform Act (S 960) reorganizes the National Institutes of Health by splitting the existing National Institute of Allergy and Infectious Diseases (NIAID) into three new institutes: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases. This directly affects NIH leadership and research operations, requiring new director appointments with 5-year terms (allowing one reappointment) and updating federal references to replace NIAID with the new institute names. The bill mandates a transition plan for NIH leadership to shift responsibilities from the old NIAID structure to the new institutes, without altering funding or creating new research programs. It focuses on administrative restructuring to better align research priorities with specific disease areas.

Maddy summaryThe PRIME Act exempts certain local meat processing from federal inspection requirements. It allows custom slaughter facilities to process animals and prepare meat products for exclusive sale within the same state - either to households or to restaurants, grocery stores, or other food businesses that serve consumers directly in that state. Facilities must comply with their state's laws regarding slaughter and processing, and the bill explicitly states it does not override state regulations on meat handling or sales. This change applies only to intrastate transactions, keeping federal oversight for meat sold across state lines.

Maddy summaryThis joint resolution (SJRES 20) seeks to block a 2023 rule from the Department of Justice and Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) that classified certain firearms with stabilizing braces as rifles under federal law. If passed, it would nullify the rule, meaning firearms equipped with these braces would no longer be subject to the rule’s classification requirements. The resolution uses the congressional disapproval process under Title 5, U.S. Code, to stop the rule from taking effect, directly affecting firearm manufacturers and owners who use stabilizing braces on weapons.

Maddy summaryThis is a ceremonial Senate resolution (SRES 110) honoring the late James George Abourezk, the first Arab American to serve in the U.S. Senate (1973-1979) from South Dakota. It commemorates his legacy, including his work re-establishing the Senate Committee on Indian Affairs and co-authoring key Native American rights legislation like the Indian Child Welfare Act. The resolution directs the Senate to adjourn in his memory and send a copy to his family, acknowledging his service as a representative and advocate for Native American communities. As a procedural resolution, it has no legislative effect beyond commemoration.

Maddy summaryThis bill creates a program allowing federal employees to identify unnecessary spending ("surplus salaries and expenses funds") in their agencies. If identified funds meet specific criteria (e.g., determined unnecessary by the Inspector General and Chief Financial Officer), the agency head must transfer the amount to the Treasury for deficit reduction (or debt reduction if no deficit exists), but may retain up to 10% of the transferred funds to pay cash bonuses to the employees who found the savings. Agencies must submit annual reports to the Treasury detailing savings, bonus awards, and the merit of employee disclosures. The program expires 6 years after enactment.